DiscoveryGate is the foremost search engine for scientists in chemistry
and related fields!
In contrast to other people that use
Google, a chemist needs to search by structures and reactions, and a
scientist needs to search by data. DiscoveryGate is the foremost
search engines for scientific data.
The power of data searches is not recognized by every scientist. Only
DiscoveryGate makes it easy to search by data.
What can DiscoveryGate do for you?
- Is it
known, or claimed?
- With one structure query search all databases. Even prophetic
(claimed , but never made) compounds are included.
- Is it
useful?
- Find all the published information about your compound, or a
similar compound.
- Is it toxic or harmful? - The
first steps are to search in Toxicity, Metabolite, PharmaPendium and
Beilstein.
- Can I
get
it? - Search among the most complete selection of
supplier catalogues,
and get in one view all suppliers that provide your compound.
- If you can't buy it, can I
make
it? - Search CrossFire Beilstein for the best preparation of a
compound. Search Synthetic Methodology Information for the best
transformation, and verify the scope and limitations using major
reference works.
For a tour and more information
please visit
www.discoverygate.com.
|
Symyx’s
DiscoveryGate also provides information related to drug discovery. “Say you
start from a chemical reaction library to synthesize a compound,” Dr. Uli
Heigl from Symyx (MDL) explains, “while browsing a reaction library, you
may get metabolite information and commercial availability and probably
information on bioactivity, physicochemical data.” He adds, “DiscoveryGate
really gives you access to all of the different data —including patents,
journal articles, and synthetic methodologies.”
from
Life Science
Technologies: Combinatorial and Computational Chemistry – Creating New
Therapeutic Compounds by Mike May and Gary Heebner, 17 March 2006 issue of
Science. |
MDL’s DiscoveryGate is the result of two
demands by our customers:
- Build an application where one can search ALL
resources and sees in an overview where the information is located. A
drill down procedure shall allow to see the information in detail.
- Build ONE interface for ALL data sources.
Asking to search over ALL resources is pretty
tough, especially if one considers that bioinformatics databases are today
part of the spectrum. Even for this MDL has an answer, but this is beyond
DiscoveryGate. DiscoveryGate concentrates on small molecules, ca. 12 million,
and reactions. This is the largest resource of chemical
information and includes 500 million observed properties.
On the left side of the screenshot you see
the databases that can be searched in DiscoveryGate. The MDL Compound Index
is a normalized database containing all structures of the above databases,
and in addition the structures from
- Thomson ISI Current Chemical
Reactions
- Thomson ISI Index Chemicus
- Derwent World Patent Index
- PubChem, National Center for
Biotechnology Information, National Library of Medicine
DiscoveryGate searches over all chemical
information in databases (secondary literature), links to journals (primary
literature), and offers a reaction classification search to
major reference
works (tertiary literature). Access to in-house databases can be
accomplished, but this is not part of the standard Internet application.
Access to Chemical Abstract Service (CAS) was prohibited by CAS. This is
understandable because DiscoveryGate is a competition to SciFinder. However,
the scope of DiscoveryGate is much wider, because it offers much more
factual data.
Download a pdf file comparing SCiFinder and DiscoveryGate.
|
Using DiscoveryGate® in medicinal chemistry and cancer
research
"Reseachers can eliminate
undesirable leads early in the lead generation process by quickly
accessing information on pharmacological effects, side effects and
drug-drug interactions for compounds or compound classes of interest, as
well as their corresponding metabolites."-Dr. Guido Kurz, CNIO
Centro Nacional de Investigaciones Oncologicas (Spanish National Cancer
Research Center).
The DiscoveryGate online platform supports this timely drug assessment
by providing researchers with quick access to a wealth of information,
all from within the same system, from data sources which are otherwise
dispersed.
Get the full story
(PDF) |
University of Wisconsin supports DiscoveryGate®
content platform for North American academic consortia
Minerva Host to offer full technical support to
consortium members licensing DiscoveryGate
SAN
RAMON, CA – November 29, 2006
– Symyx (MDL) is pleased to announce that the University of
Wisconsin will provide full technical support to all members of the
North American MINERVA consortium that license either the full
DiscoveryGate®
content
platform or the Beilstein and/or Gmelin databases using the
DiscoveryGate platform. The University of Wisconsin currently hosts the
MINERVA and MENTOR programs that provide students, faculty and
researchers at over 100 North American universities with unlimited
access to their respective licensed databases, including CrossFire
Beilstein, Crossfire Gmelin and MDL®
ISIS
chemical sourcing, bioactivity and synthetic methodology databases.
“The
University of Wisconsin is pleased to expand our role with the academic,
scientific research and library communities by supporting DiscoveryGate
from Symyx (MDL),” said Nolan Pope, Associate Director for Technology,
General Library System, UW-Madison. “Extending technical and user
support to the DiscoveryGate platform enables the growing number of
North American universities to benefit from this important chemistry and
life science resource.”
DiscoveryGate serves tens of thousands of eligible users at more than
400 commercial, academic and government institutions worldwide and is
supported on both the Microsoft Windows® and Apple Macintosh®
OS X platforms. Because DiscoveryGate is widely deployed in the
commercial research environment, hands-on experience with DiscoveryGate
in the university setting will prepare students for success in today’s
highly competitive job market.
DiscoveryGate’s unique integration and linking of content enables
researchers to compare information and results that are not available
through other systems. With the indexing of important new data sources
this year (e.g., PharmaPendium™ drug safety resource, PubChem®
database, GeneGo systems biology/pathway analysis platform, etc.),
DiscoveryGate now provides detailed scientific information on more than
22 million chemical compounds, 11 million reactions and 500 million
observed chemical facts, including synthesis, bioactivity, metabolism,
toxicology, physical property, chemical sourcing, pharmacology and
patent data—all from a single query.
Researchers can access 17 databases including the Beilstein and Gmelin
databases (which are also available on the CrossFire system from MDL
Information Systems GmbH), MDL®
Available Chemicals Directory, MDL®
Drug
Data Report, MDL®
Toxicity Database and authoritative reference works on synthetic
methodology. Researchers can also search compounds in PubChem and the
Derwent World Patents Index®,
and they can link to over 20,000 journal titles (with additional
licenses required to access certain third-party content).
“Researchers at more than 20 academic institutions in North America
including Stanford, Harvard and the University of Chicago are currently
using the DiscoveryGate platform to answer research questions—and more
are expected by the end of the year,” said Symyx (MDL) President and
CEO Lars Barfod. “Symyx (MDL) appreciates the University of Wisconsin’s
support of the growing DiscoveryGate community in North America.”
DiscoveryGate for academia features a campus-wide access model. When an
institution licenses DiscoveryGate, any number of eligible researchers
at the institution may use the service—access is not limited to a few
people at a time. To learn more about how DiscoveryGate helps academic
researchers find the information they need, visit www.discoverygate.com,
contact your Symyx (MDL) Account Manager or request information at
www.mdl.com.
|
Download a discoverygate datasheet in Russian
or
|